GLP has been demonstrated to protect against colitis and tumorigenesis by reducing the production of pro-inflammatory cytokines such as IL-1β, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) [7]. This evidence concerns the gene NOS2 and colitis.